Review The SDS Document
DOWNLOADProduct Details
Formula
C19H20ClNO4
MW
361.83
Purity
>97%
Solubility (DMSO Mg/MI)
70
Bio Chemical Notes
Bezafibrate decreases low density lipoproteins and increases high density lipoproteins. For the treatment of primary hyperlipidaemia types IIa, IIb, III, IV and V. An agonist of PPARalpha. Ref: Drugs. 1987; 33 (6), 539-576.